Rockefeller Capital Management L.P. Collegium Pharmaceutical, Inc Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$16.14 - $23.55 $807 - $1,177	-50 Reduced 43.86%	64 $1,000
Q3 2022 Nov 02, 2022	BUY	$15.46 - $20.1 $139 - $180	9 Added 8.57%	114 $1,000
Q2 2022 Aug 12, 2022	BUY	$14.22 - $20.88 $341 - $501	24 Added 29.63%	105 $1,000
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $860 - $1,125	50 Added 161.29%	81 $1,000
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $542 - $661	31 New	31 $0
Q4 2020 Feb 12, 2021	SELL	$17.83 - $22.29 $12,891 - $16,115	-723 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$15.78 - $20.82 $1,893 - $2,498	120 Added 19.9%	723 $15,000
Q2 2020 Aug 12, 2020	BUY	$15.49 - $23.51 $4,259 - $6,465	275 Added 83.84%	603 $11,000
Q1 2020 May 12, 2020	BUY	$13.89 - $25.45 $4,555 - $8,347	328 New	328 $5,000

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.